Mariana
Fernández Caggiano
GlaxoSmithKline (United Kingdom)
Londres, Reino UnidoPublications in collaboration with researchers from GlaxoSmithKline (United Kingdom) (1)
2018
-
The TAB1-p38α complex aggravates myocardial injury and can be targeted by small molecules
JCI insight, Vol. 3, Núm. 16